AbbVie is a global, research-based biopharmaceutical company. The company's mission is to use its expertise, dedicated people and unique approach to innovation to develop and market advanced therapies that address some of the world's most complex and serious diseases.
Company Growth (employees)
Type
Public
HQ
North Chicago, US
Founded
2013
Size (employees)
30,000 (est)+8%
Website
abbvie.com
AbbVie was founded in 2013 and is headquartered in North Chicago, US

Key People/Management at AbbVie

Richard A. Gonzalez

Richard A. Gonzalez

Chairman of the Board and Chief Executive Officer

AbbVie Office Locations

AbbVie has an office in North Chicago
North Chicago, US (HQ)
1 Waukegan Rd

AbbVie Financials and Metrics

AbbVie Financials

AbbVie's revenue was reported to be $25.6 b in FY, 2016 which is a 12% increase from the previous period.
USD

Revenue (FY, 2016)

25.6 b

Revenue growth (FY, 2015 - FY, 2016), %

12%

Gross profit (FY, 2016)

19.8 b

Gross profit margin (FY, 2016), %

77%

Net income (FY, 2016)

6 b

Market capitalization (17-Oct-2017)

147.5 b

Cash (31-Dec-2016)

5.1 b

EV

179.2 b
AbbVie's current market capitalization is $147.5 b.
USDFY, 2013FY, 2014FY, 2015FY, 2016

Revenue

18.8 b20 b22.9 b25.6 b

Revenue growth, %

6%15%12%

Cost of goods sold

4.6 b4.4 b4.5 b5.8 b

Gross profit

14.2 b15.5 b18.4 b19.8 b
USDFY, 2013FY, 2014FY, 2015FY, 2016

Cash

9.6 b8.3 b8.4 b5.1 b

Accounts Receivable

3.9 b3.7 b4.7 b4.8 b

Inventories

1.2 b1.1 b1.7 b1.4 b

Current Assets

17.8 b16.1 b16.3 b16.2 b
USDFY, 2013FY, 2014FY, 2015FY, 2016

Net Income

4.1 b1.8 b5.1 b6 b

Accounts Receivable

681 m(172 m)(1.1 b)(71 m)

Inventories

(56 m)(203 m)(434 m)(38 m)

Accounts Payable

(426 m)(193 m)1.5 b(1.2 b)
USDY, 2016

EV/CFO

25.4 x

Revenue/Employee

1 m

Debt/Equity

7.9 x

Debt/Assets

0.6 x

Financial Leverage

14.3 x
Show all financial metrics

AbbVie Acquisitions / Subsidiaries

Acquired CompanyDateDeal Size
Stem CentRxApril 28, 2016$5.8 b

AbbVie Market Value History

AbbVie Median Salaries

Source: 442 public H-1B filings from AbbVie

Traffic Overview of AbbVie

AbbVie Online and Social Media Presence

AbbVie News and Updates

Merck targets high-risk military veterans for hepatitis C lessons

Veterans are three times more likely to have hepatitis C than the general population—and antiviral drugmaker Merck & Co. wants to make sure they know that.

Salivary Gland Infection Market Estimated to Witness a Staggering Growth of USD 3622.6 Million by 2023

Global salivary gland infection market information, by diagnosis (plain radiography, sialography), by treatment, by end user- Forecast till 2023 Posted via Industry Today. Follow us on Twitter @IndustryToday

NIH partners with biopharma to speed development of cancer immunotherapy work

The Partnership for Accelerating Cancer Therapies - PACT - is a five-year, $215 million collaboration and part of the Cancer Moonshot.

Biologics Market 2017 Accrues Vivaciously By 2027

Global Biologics Information, by Product type (vaccines, blood and blood products, allergenic extracts, human cells and tissues, proteins and others), by applications (Rheumatoid arthritis, Renal failure, Anemia, Cancer, Diabetes and others), by source (Humans, Avian Cell Culture, Yeast, Bacteria, I…

What's new on pharma's worry list? Cybersecurity, natural disasters and much more

Accounting and advisory firm BDO sifted through SEC filings to discover just what the top 100 life sciences companies are most worried about these days.

AbbVie hit with $140M verdict in second bellwether AndroGel case

A jury slapped AbbVie with a $140 million verdict in the second AndroGel case to reach a trial.
Show more

AbbVie Company Life and Culture

You may also be interested in